NovoCure Ltd — Director's Dealing 2020

May 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2020-05-08

Reporting Person: Weinberg Uri (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-08	Ordinary Shares	M	1402	$63.84	Acquired	25629	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-08	Restricted Share Units	$0.0	M	1402	Disposed		Ordinary Shares (1402.0)	Direct

Footnotes

F1: Fully vested as of the date hereof.